A systematic review to summarise current evidence about the role of LHRH agonists in the adjuvant treatment of ER+ early breast cancer in pre-menopausal women, with a view to providing evidence to support the information needs of women with breast cancer, clinicians, media and policy makers.
This resource has been superseded in-full or in-part by Review Use of taxanes for neo and adjuvant treatment early and locally advanced breast cancer.
|File size:||399.83 KB|
|Cancer Type:||Breast cancer|
|Publication Audience:||Resources for health professionals|
This resource is 10 years or older and has been rescinded by Cancer Australia. It is available to the public for research and reference purposes only. Cancer Australia assumes no legal liability or responsibility for errors or omissions contained within.